| Q70023468 | A new group of oncornaviruses |
| Q84245607 | A novel fish herpesvirus of Osmerus eperlanus |
| Q44537827 | Biochemical and immunological characterization of structural proteins from retrovirus-D/New England and comparison to Mason-Pfizer monkey virus and permanent human fibroblast virus |
| Q42803907 | Characterization of an established cell line (SH-3) derived from pleural effusion of patient with breast cancer |
| Q36619409 | Electron microscopy of the nucleocapsid from disrupted Moloney murine leukemia virus and of associated type VI collagen-like filaments. |
| Q53649200 | Endogenous retroviruses in the human genome—A point of view |
| Q38052662 | Envelope Antigens of Oncoviruses |
| Q44184265 | Evidence for type-C retrovirus production by Burkitt's lymphoma-derived cell line |
| Q35058112 | Evolution of primate oncornaviruses: An endogenous virus from langurs (Presbytis spp.) with related virogene sequences in other Old World monkeys |
| Q40155596 | Factors which influence inactivation of vesicular stomatitis virus by fresh human serum |
| Q71418639 | Further evidence from tryptic peptide analysis for heterogeneity among type D retroviruses |
| Q41582828 | Identification of human type D retrovirus as a contaminant in a neuroblastoma cell line |
| Q39997606 | Immunological cross reactivity of Mason–Pfizer monkey virus with type C RNA viruses endogenous to primates |
| Q36561769 | Immunological properties of two polypeptides of Mason-Pfizer monkey virus |
| Q36820420 | Isolation of a type D retrovirus from B-cell lymphomas of a patient with AIDS. |
| Q45894500 | Isolation of foamy virus from patients with de Quervain thyroiditis |
| Q73049139 | Markers of type D retroviruses in children with Burkitt's-type lymphoma |
| Q41024118 | Mason-Pfizer like virus in kidney grafted patients |
| Q36568296 | Mason-Pfizer monkey virus: analysis and localization of virion proteins and glycoproteins |
| Q37499931 | Mason-Pfizer virus RNA genome: relationship to the RNA of morphologically similar isolates and other oncornaviruses |
| Q33813565 | Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma |
| Q39394811 | Oncogenic viruses: Implications for human diseases (Part II) |
| Q40001942 | Phenotypic mixing of vesicular stomatitis virus and D-type oncornavirus |
| Q41237346 | Radioimmunoassay for the major structural protein of mason-pfizer monkey virus: Attempts to detect the presence of antigen or antibody in humans |
| Q39903223 | Remarks on the ultrastructure of type A, B, and C virus particles |
| Q40228949 | Retrovirus-like particles in EBV-negative Burkitt's lymphoma cell line but not in EBV-DNA-positive lines from patients with ataxia telangiectasia and Down's syndrome |
| Q35120665 | Sequence homology between the RNA of Mason-Pfizer monkey virus and the RNA of human malignant breast tumors |
| Q42831081 | Sequences associated with intracisternal a particles are reiterated in the mouse genome |
| Q39365078 | Terminal dilution purification of adenovirus prototypes, and the antigenic relationship between types 4, 16 and 14 |
| Q66703920 | Treating chronic relapsing Guillain-Barré syndrome by plasma exchange |
| Q45841218 | Type A oncornavirus-like particles in turkey bone marrow cells transformed by avian leukemia virus |
| Q71081329 | Type D retroviruses from human cells do not contain a minor glycoprotein shared by old world monkey type D viruses |
| Q45803346 | Ultrastructural studies on Maedi-Visna virus |
| Q37384058 | Unintended spread of a biosafety level 2 recombinant retrovirus |
| Q39903659 | Virion and tumor cell antigens of C-type rna tumor viruses |